Based in Zurich, Switzerland

Swiss Precision.
Korean Insight.

Independent Korea healthcare intelligence for international MedTech and healthcare decision makers.

Korea is more than a market. It is a test bed. Entering it requires more than data: how decisions are made, how communication is read, and where misalignment creates delay.

Services

Support for decisions in Korea.

Research, interpretation and on-the-ground support for teams that need a clearer view of Korean healthcare.

01

Market Intelligence

Independent analysis of policy, reimbursement, regulation, hospitals and developments that affect market entry and strategy.

02

Local Research & Scouting

Targeted research on companies, partners, competitors and opportunities to support decisions in Korea.

03

Korea Representation

Presence at conferences, industry events and selected meetings, with concise reporting for your team.

Latest Insights

Why Korean healthcare developments matter.

Short briefings on market access, regulation, hospitals, MedTech and Korean companies expanding into Europe.

31 Aug 2026 · Competitive

Sky Labs brings its cuffless BP ring to Europe through IEM

A Korean device enters Europe by plugging into a German incumbent’s channel — not head-to-head.

Read briefing
28 Aug 2026 · Market access

How Coreline Soft is winning Germany’s lung-screening market

Korean medical AI is attaching to reimbursed pathways through Canon’s procurement channel.

Read briefing
27 Aug 2026 · Regulation

Korea redraws the line between wellness tech and devices

MFDS guidance now decides which connected products need approval — and which do not.

Read briefing
Editorial Principles

Context over headlines.

Every piece is grounded in public evidence and reviewed for accuracy. We value independent analysis over speed or volume.

About

Korea healthcare intelligence from Zurich.

Arirang Insight is a Zurich based practice for European MedTech and healthcare teams that need a clear reading of Korea, including policy, access, hospitals and competitive moves, without relying on translated headlines or local distributors.

The work draws on Swiss MedTech scientific affairs across Asia Pacific, Korean health system research, and Europe and Korea business development. Analysis is independent: we do not sell devices or represent a Korean distributor.

We explain why a development matters, what it signals, and how it may affect market access, partnerships, regulation and competitive position.

What we cover
PolicyHealthcare policy
MarketMarket intelligence
AccessReimbursement and market access
DeliveryHospitals and care delivery
MedTechMedical technology and industry
DigitalDigital health and AI
TrendsAgeing and workforce
Who we work with
Clients Healthcare and MedTech executives, strategy teams, investors and researchers
Upcoming Events

Korea, Switzerland, Germany.

Selected healthcare and MedTech meetings where market questions, partners and competitors show up in the same room.

World Hospital Congress Hospital leaders and a Korea pavilion — useful for delivery, procurement and partnership mapping.
Seoul
IFAS Swiss hospital and healthcare trade fair in Zurich.
Zürich
MEDICA / COMPAMED The European meeting point for devices, suppliers and Korean exhibitors entering the EU.
Düsseldorf

Need eyes on the ground? Selected coverage, scouting and a short post-event note.

Ask about event coverage
Contact

Need a clearer read on Korea?

Send the market question, company, technology or strategic issue you are examining.

contact@ariranginsight.ch Zurich, Switzerland · Connected to Seoul

Send an inquiry